And I'm chiming in to point out how you repeatedly address your "concerns" about Cytodyn's financial situation, which is really unusual for a pre revenue biotech company, isn't it?
Just to finish your usual soft bash (selling shares, how much you banked etc.) with a heart wrenching story of someone who died that might have been saved by leronlimab, in order to avoid your post from being deleted.